metformin has been researched along with Kidney Diseases, Cystic in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Kidney Diseases, Cystic: A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally (KIDNEY, CYSTIC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both bortezomib and metformin have been proposed as potential therapeutics in TSC." | 5.38 | Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). ( Auricchio, N; Kwiatkowski, DJ; Malinowska, I; Manning, BD; Shaw, R, 2012) |
| "Both bortezomib and metformin have been proposed as potential therapeutics in TSC." | 1.38 | Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). ( Auricchio, N; Kwiatkowski, DJ; Malinowska, I; Manning, BD; Shaw, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, T | 1 |
| Yang, Y | 1 |
| Hu, Z | 1 |
| Auricchio, N | 1 |
| Malinowska, I | 1 |
| Shaw, R | 1 |
| Manning, BD | 1 |
| Kwiatkowski, DJ | 1 |
2 other studies available for metformin and Kidney Diseases, Cystic
| Article | Year |
|---|---|
A novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.
Topics: Aftercare; Central Nervous System Diseases; Dental Enamel; Diabetes Mellitus, Type 2; Hepatocyte Nuc | 2020 |
Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC).
Topics: Animals; Body Weight; Boronic Acids; Bortezomib; Disease Models, Animal; Humans; Immunoblotting; Imm | 2012 |